News

BMJ1d
Prognostic laboratory markers of joint damage in rheumatoid arthritis
Objective: To investigate whether determination of a set of laboratory markers at baseline provides prognostic information on joint damage in hands and feet in rheumatoid arthritis. Methods: 183 ...
BMJ1d
Six months open label trial of leflunomide in active ankylosing spondylitis
Objective: To examine the potential therapeutic effects of leflunomide in patients with active AS in an open label study. Patients and methods: Twenty patients with AS fulfilling the 1984 modified New ...
BMJ1d
High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis
Objective Dactylitis is a hallmark of psoriatic arthritis (PsA) where flexor tenosynovitis is common. This study explored the microanatomical basis of dactylitis using high-resolution MRI (hrMRI) to ...
BMJ2d
Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis
1 UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland 2 UCD School of Mathematical Sciences, University College Dublin, Dublin, Ireland Objective ...
BMJ2d
Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study
OBJECTIVE To evaluate in a prospective study whether patients with polymyalgia rheumatica (PMR) and patients with rheumatoid arthritis (RA) with PMR-like onset show distinctive clinical and laboratory ...
BMJ2d
Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus
2 Department of Internal Medicine, General Hospital of Kufstein, Kufstein, Austria 3 Department of Internal Medicine I, Innsbruck Medical University, Innsbruck, Austria 4 Department of Internal ...
BMJ3d
Ankylosing spondylitis: an overview
1 Department of Gastroenterology and Rheumatology, Free University, Berlin, Germany 2 Rheumazentrum Ruhrgebiet, Herne, Germany and Department of Gastroenterology and Rheumatology, Free University, ...
BMJ3d
‘Treat to target’: moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis
Correspondence to Professor Dan Atar, Department of Cardiology, Division of Medicine B, Oslo University Hospital, Kirkeveien 166, Oslo 0407, Norway; dan.atar{at}medisin.uio.no The principle of ‘treat ...
BMJ3d
The International Classification of Functioning, Disability and Health (ICF) Core Sets for rheumatoid arthritis: a way to specify functioning
1 Department of Physical Medicine and Rehabilitation, Ludwig-Maximilians-University, Munich, Germany 2 ICF Research Branch of the WHO FIC CC (DIMDI), IMBK—Department of Physical Medicine and ...
BMJ4d
CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis
5 Department of Orthopedic Surgery and Department of Bioengineering, Stanford University, Stanford, California, USA Correspondence to Dr William H Robinson, Division of Immunology and Rheumatology, ...
BMJ4d
Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort
1 Section of Rheumatology, Department of Clinical Sciences, Lund University, Lund, Sweden 2 Department of Orthopedics, Musculoskeletal Sciences, Clinical Sciences Lund, Lund University, Lund, Sweden 3 ...